Last edition
News about "Sanofi Warns of Near-Term Weakness "
Sanofi Warns of Near-Term Weakness in US Vaccine Demand Amid Antivax Rhetoric
French pharmaceutical company Sanofi expects near-term weakness in vaccine sales in the United States, attributing the anticipated softness to growing scepticism around immunizations that the company says has been fueled by misinformation.
Sanofi Warns Of Near-Term Weakness | 15/01/2026 | By Darshana | 213
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members